Pennsylvania Code › Title 28 - HEALTH AND SAFETY › Part III - Prevention of Diseases › Chapter 26 - OPIOID TREATMENT AGREEMENTS-TEMPORARY REGULATIONS › Section 26.3 - Definitions

Current through Register Vol. 54, No. 28, July 13, 2024
The following words and phrases when used in this chapter
				  have the following meanings unless the context clearly indicates
				  otherwise:
Acute pain
- Pain that comes on quickly, may
				  be severe, but lasts a relatively short time and is provoked by a specific
				  condition or injury.
Baseline test
- The initial assessment
				  through a urine drug test to:
(1)
				identify the presence of an illegal substance prior to prescribing a controlled
				substance; or
(2) assess the
				presence or absence of a prescribed drug or drug class.
Chronic pain
- Pain that persists or
				  progresses over a period of time that may be related to another medical
				  condition and is resistant to medical treatment. The term does not include
				  acute pain.
Controlled substance
- A drug, substance or
				  immediate precursor included in Schedules II-V of section 4 of the act of April
				  14, 1972 (P.L. 233, No. 64) (35 P.S. §§
										780-101-780-144), known as The Controlled
				  Substance, Drug, Device and Cosmetic Act.
Definitive drug test
- A qualitative or
				  quantitative urine drug test used to identify specific drugs, specific drug
				  concentrations and associated metabolites.
Department
- The Department of Health of the
				  Commonwealth.
Individual
- A natural person who is at least
				  18 years of age.
Medical emergency
- A situation that, in the
				  good faith professional judgment of the prescriber, creates a time sensitive
				  threat of serious risk to the life or physical health of a person. The term
				  includes treatment received in an emergency department or urgent care center
				  under the act of November 2, 2016 (P.L. 976, No. 122), known as the Safe
				  Emergency Prescribing Act (35 P.S. §§
										873.1-873.9).
Opioid
- Any of the following:
(1) A preparation or derivative of
				opium.
(2) A synthetic narcotic
				that has opiate-like effects but is not derived from opium.
(3) A group of naturally occurring peptides
				that bind at or otherwise influence opiate receptors, including an opioid
				agonist.
Periodic test
- A urine drug test that
				  screens for a selection of drugs.
Prescriber
- As defined in the act of
				  October 27, 2014 (P.L. 2911, No. 191), known as the Achieving Better Care by
				  Monitoring All Prescriptions Program (ABC-MAP) Act (35 P.S. §§
										872.1-872.40).
Prescription or prescription order
- A
				  written, oral or electronic order for a controlled substance, other drug or
				  medication, or device for medication which is dispensed to or for an ultimate
				  user but does not include an order for a controlled substance, other drug or
				  medication, or device for medication which is dispensed for immediate
				  administration to the ultimate user.
Presumptive positive drug test
- A urine drug
				  test that is used to identify suspected possible use or nonuse of drugs or a
				  drug class that may be followed by a definitive test to specifically identify
				  drugs or metabolites.
Targeted test
- A urine drug test ordered at
				  the discretion of a prescriber, based on observation of the prescriber and
				  related circumstances that enhance clinical decision making.
Treatment agreement
- A document signed by a
				  prescriber and individual that contains a statement to ensure that the
				  individual understands:
(1) Treatment
				responsibilities.
(2) The
				conditions of medication use.
(3)
				The conditions under which the treatment of the individual may be
				terminated.
(4) The
				responsibilities of the prescriber